These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 4125683)
1. Infectious complications in cancer patients treated with chemical immunosuppressive agents. Armstrong D Transplant Proc; 1973 Sep; 5(3):1245-8. PubMed ID: 4125683 [No Abstract] [Full Text] [Related]
2. Efficacy of human gamma-globulin preparation in experimental pseudomonas aeruginosa infections in mice and its mode of action. Kamimura T Arzneimittelforschung; 1984; 34(11):1528-34. PubMed ID: 6084512 [TBL] [Abstract][Full Text] [Related]
3. [The use of immunotherapy in acute parablastic leukosis]. Aurich G; Plenert W; Zintl F; Polzin G; Blau HJ; Kruse H Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(1):21-8. PubMed ID: 4104079 [No Abstract] [Full Text] [Related]
4. Leukocyte transfusion therapy for patients with host-defense failure. McCredie KB; Freireich EJ; Hester JP; Vallejos C Transplant Proc; 1973 Sep; 5(3):1285-9. PubMed ID: 4517031 [No Abstract] [Full Text] [Related]
5. [Study of infection during acute leukemia (139 cases). The parameters of the infection: neutropenia and immunodepression. Respective role of the endogenous flora and exogenous contamination]. Loiseau-Marolleau ML Pathol Biol (Paris); 1970 Nov; 18(21):975-83. PubMed ID: 4991514 [No Abstract] [Full Text] [Related]
6. [The treatment of chronic lymphatic leukemia]. Obrecht P; Heilmeyer L Munch Med Wochenschr; 1966 Sep; 108(35):1717-20. PubMed ID: 4173541 [No Abstract] [Full Text] [Related]
7. [Possibilities and prospects of immunoprophylaxis and immunotherapy of pyocyanic infections under supervision of these infections using epidemiological markers]. Meitert E; Meitert T Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(4):289-302. PubMed ID: 6320334 [No Abstract] [Full Text] [Related]
8. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients. Pier GB Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760 [TBL] [Abstract][Full Text] [Related]
9. [The necessity of i.v. human immunoglobulin therapy for Pseudomonas aeruginosa infection]. Nishimura T Nihon Rinsho; 1991 Oct; 49(10):2431-40. PubMed ID: 1721099 [No Abstract] [Full Text] [Related]
10. Controlled prospective trial of Pseudomonas aeruginosa vaccine in children with acute leukemia. Haghbin M; Armstrong D; Murphy ML Cancer; 1973 Oct; 32(4):761-6. PubMed ID: 4201654 [No Abstract] [Full Text] [Related]
12. Pseudomonas aeruginosa infections: persisting problems and current research to find new therapies. Ann Intern Med; 1975 Jun; 82(6):819-31. PubMed ID: 806246 [TBL] [Abstract][Full Text] [Related]
13. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes. Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231 [TBL] [Abstract][Full Text] [Related]
14. [Antibody depression from cytostatic and radiologic treatment]. Neidhardt M Monatsschr Kinderheilkd (1902); 1969 Apr; 117(4):282-4. PubMed ID: 4194276 [No Abstract] [Full Text] [Related]